Sign inGet started

Dolan Dan

Insider CIK 1826818 · RDUS VP of Finance · NBRV Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NBRV Nabriva Therapeutics plc M Exercise deriv2022-08-112022-08-1583,200— $083,200SEC↗
NBRV Nabriva Therapeutics plc M Exercise deriv2022-08-112022-08-1541,600— $00SEC↗
NBRV Nabriva Therapeutics plc M Exercise deriv2022-08-112022-08-1541,600— $041,600SEC↗
NBRV Nabriva Therapeutics plc M Exercise deriv2022-08-112022-08-1583,200— $00SEC↗
NBRV Nabriva Therapeutics plc A Award deriv2022-01-282022-02-0183,200— $083,200SEC↗
NBRV Nabriva Therapeutics plc A Award deriv2022-01-282022-02-0141,600— $041,600SEC↗
NBRV Nabriva Therapeutics plc A Award deriv2021-03-312021-04-02100,000— $0100,000SEC↗
RDUS Radius Health, Inc. A Award deriv2020-11-092020-11-1012,000— $012,000SEC↗